Form D · Other Health Care
Tissue Analytics, Inc.
Baltimore, MD · CIK 0001633370
Offering snapshot reported Jan 23, 2018 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 11, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 23, 2018 | Initial | $5,000,000 | No comparison | 12 | SEC filing |
| Mar 14, 2016 | Initial | $1,925,000 | No comparison | 4 | SEC filing |
| Feb 12, 2015 | Initial | $0 | No comparison | 6 | SEC filing |
| Feb 12, 2015 | Amendment | $750,000 | $750,000vs Feb 12, 2015 | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-303910
Source: Form D, filed Jan 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gabriel Brat | Director |
| Joshua Budman | Director |
| Karen Griffith Gryga | Director |
| Kevin Keenahan | Director, Executive |
| David Kim | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3 South Frederick Street Suite 800
Baltimore, MD, 21202
Baltimore, MD, 21202